Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergy Drugs Forced OTC Switch Not Unconstitutional "Taking" - WellPoint

This article was originally published in The Tan Sheet

Executive Summary

An FDA-mandated OTC switch of second-generation antihistamines would not result in an unconstitutional "deprivation of property" for drug marketers, WellPoint Health Networks says in comments to FDA.

You may also be interested in...



FDA Forced OTC Switch Process Ambiguities Revealed At Subcmte. Hearing

FDA does not have an established procedure in place to prevent the disclosure of protected trade secrets in the event of a forced Rx-to-OTC switch, Center for Drug Evaluation & Research Director Janet Woodcock, MD, told a House panel June 13.

Antihistamines OTC Switch Battle Moves To Capitol Hill

A House subcommittee will examine FDA's legal authority to initiate an Rx-to-OTC switch without the sponsor's consent during a June 13 hearing.

FDA, Rx Antihistamine Makers' Next Move: Compromise?

A negotiated compromise between FDA and the manufacturers of second-generation antihistamines seems the most logical way to resolve the legal, regulatory and financial obstacles facing both sides.

Related Content

Topics

UsernamePublicRestriction

Register

PS092736

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel